Exploring Endothelial Expansion on a Chip.

Human Umbilical Vein Endothelial Cells (HUVECs) Vascular Endothelial Growth Factor (VEGF) Viscous Finger Patterning (VFP) angiogenesis-on-a-chip lumen micro-milling microfluidics microvessel sprouting vessel-on-a-chip

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
02 Dec 2022
Historique:
received: 26 10 2022
revised: 22 11 2022
accepted: 29 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Angiogenesis is the development of new blood vessels from the existing vasculature. Its malfunction leads to the development of cancers and cardiovascular diseases qualified by the WHO as a leading cause of death worldwide. A better understanding of mechanisms regulating physiological and pathological angiogenesis will potentially contribute to developing more effective treatments for those urgent issues. Therefore, the main goal of the following study was to design and manufacture an angiogenesis-on-a-chip microplatform, including cylindrical microvessels created by Viscous Finger Patterning (VFP) technique and seeded with HUVECs. While optimizing the VFP procedure, we have observed that lumen's diameter decreases with a diminution of the droplet's volume. The influence of Vascular Endothelial Growth Factor (VEGF) with a concentration of 5, 25, 50, and 100 ng/mL on the migration of HUVECs was assessed. VEGF's solution with concentrations varying from 5 to 50 ng/mL reveals high angiogenic potential. The spatial arrangement of cells and their morphology were visualized by fluorescence and confocal microscopy. Migration of HUVECs toward loaded angiogenic stimuli has been initiated after overnight incubation. This research is the basis for developing more complex vascularized multi-organ-on-a-chip microsystems that could potentially be used for drug screening.

Identifiants

pubmed: 36502120
pii: s22239414
doi: 10.3390/s22239414
pmc: PMC9741423
pii:
doi:

Substances chimiques

Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Center
ID : 2021/41/B/ST4/01725

Références

Cell. 2019 Mar 7;176(6):1248-1264
pubmed: 30849371
Lab Chip. 2021 Jan 21;21(2):421-434
pubmed: 33351007
Sci Rep. 2020 Nov 19;10(1):20142
pubmed: 33214583
Adv Healthc Mater. 2022 Jun;11(12):e2102581
pubmed: 35286780
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7968-73
pubmed: 24843171
APL Bioeng. 2019 Jul 30;3(3):036102
pubmed: 31431938
Biomaterials. 2020 Jan;229:119547
pubmed: 31710953
Am J Physiol Cell Physiol. 2021 Jan 1;320(1):C92-C105
pubmed: 33176110
J Intern Med. 2013 Feb;273(2):156-65
pubmed: 23216817
Micromachines (Basel). 2022 Jan 29;13(2):
pubmed: 35208349
EBioMedicine. 2018 Jan;27:225-236
pubmed: 29289530
J Cancer. 2020 May 18;11(15):4474-4494
pubmed: 32489466
Medicina (Kaunas). 2018 Mar 25;54(1):
pubmed: 30344239
Adv Wound Care (New Rochelle). 2014 Oct 1;3(10):647-661
pubmed: 25302139
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
Front Physiol. 2020 Jun 18;11:684
pubmed: 32625119
ACS Nano. 2021 Jan 26;15(1):338-350
pubmed: 33231435
J Lab Autom. 2012 Apr;17(2):96-103
pubmed: 22357560
Cell. 1996 Aug 9;86(3):353-64
pubmed: 8756718
J Leukoc Biol. 2016 Nov;100(5):979-984
pubmed: 27406995
Cells. 2021 Jul 28;10(8):
pubmed: 34440684
Annu Rev Cell Dev Biol. 2011;27:563-84
pubmed: 21756109
Eur Heart J. 2003 Apr;24(7):586-603
pubmed: 12657217
Biomicrofluidics. 2019 Dec 05;13(6):064122
pubmed: 31832120
Annu Rev Biomed Eng. 2021 Jul 13;23:407-432
pubmed: 33863238
Lab Chip. 2012 Aug 21;12(16):2815-22
pubmed: 22767334
Biotechnol Bioeng. 2020 Nov;117(11):3572-3590
pubmed: 32648934
Front Cell Dev Biol. 2021 Dec 08;9:781172
pubmed: 34957110
Neoplasia. 2018 Jun;20(6):610-620
pubmed: 29747161
Semin Cancer Biol. 2009 Oct;19(5):329-37
pubmed: 19482086
Nat Rev Cancer. 2002 Oct;2(10):795-803
pubmed: 12360282
Bioengineering (Basel). 2020 Feb 18;7(1):
pubmed: 32085464
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Adv Healthc Mater. 2014 Apr;3(4):609-16
pubmed: 23983140
Cancers (Basel). 2021 Aug 05;13(16):
pubmed: 34439103
Cell Mol Life Sci. 2020 May;77(9):1745-1770
pubmed: 31690961
Microvasc Res. 2003 Sep;66(2):102-12
pubmed: 12935768
Biosensors (Basel). 2022 Aug 01;12(8):
pubmed: 36004984
Biomicrofluidics. 2018 May 16;12(4):042204
pubmed: 29861815
Cell. 2015 Apr 23;161(3):595-609
pubmed: 25892225
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Genes Cancer. 2011 Dec;2(12):1117-33
pubmed: 22866203
Adv Healthc Mater. 2017 Aug;6(15):
pubmed: 28544639
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15342-7
pubmed: 21876168

Auteurs

Joanna Konopka (J)

Faculty of Chemistry, Warsaw University of Technology, 00-661 Warszawa, Poland.

Dominik Kołodziejek (D)

Faculty of Chemistry, Warsaw University of Technology, 00-661 Warszawa, Poland.

Magdalena Flont (M)

Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, 02-822 Warszawa, Poland.

Agnieszka Żuchowska (A)

Faculty of Chemistry, Warsaw University of Technology, 00-661 Warszawa, Poland.

Elżbieta Jastrzębska (E)

Faculty of Chemistry, Warsaw University of Technology, 00-661 Warszawa, Poland.
Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, 02-822 Warszawa, Poland.

Zbigniew Brzózka (Z)

Faculty of Chemistry, Warsaw University of Technology, 00-661 Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH